Phase 3 Trials at Kidney Week 2026 Show New Promise for IgA Nephropathy Care
Phase 3 trial results presented at ASN Kidney Week 2026 show that atacicept, sibeprenlimab and telitacicept provided kidney protection for ...
Phase 3 trial results presented at ASN Kidney Week 2026 show that atacicept, sibeprenlimab and telitacicept provided kidney protection for ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine